I think pilot production capacity will cover their operating...

I think pilot production capacity will cover their operating costs. If they secure big contracts with up some up front outlay I can't imagine EMV being squeezed on funding for scale up either. The history of good capital management and general and strong allergy to any sort of dilution or cost of capital tells me they are thinking about this 100%.We could be looking at one of the most successful medical device companies to come out of Australia (measured by equity spent vs value created). and to estimate circa A$30m of revenue from initial hardware sales (probably just 50% of their total revenue component) with only modest resource additions sounds fantastic. I haven't seen a prospect as attractive as EMVs